Tegafur-Uracil(TEGASIL) 경구 투여 후 발생한 고정 약진 1예 = Short Report : A Case of Fixed Drug Eruption Induced by Tegafur-Uracil(TEGASIL)

다국어 초록 (Multilingual Abstract)

A mixture of tegafur and uracil (TEGASIL) is a common antineoplastic agent. Tegafur is a fluoropyrimidine structurally similar to 5-fluorouracil (5-FU); uracil slows the degradation of 5-FU by dihydropyrimidine dehydrogenase, which results in higher 5-FU concentrations in tumors. Mucocutaneous side effects induced by this agent are rare and include photosensitivity of lichenoid and eczematous types, acral erythema, hyperpigmentation and palmoplantar keratoderma. However, there have been no reports of fixed drug eruption associated with TEGASIL. We report here on a case of fixed drug eruption due to oral TEGASIL. (Korean J Dermatol 2010;48(2):155∼157)

참고문헌 (Reference)

1 Takiuchi H, "Uracil-tegafur in gastric carcinoma:a comprehensive review" 16 : 2877-2885, 1998

2 Listosella E, "Tegafur induced acral hyperpigmentation" 48 : 205-207, 1991

3 Horia T, "Photosensitivity due to a fluorouracil derivative" 114 : 1498-1500, 1978

4 Korkij W, "Fixed drug eruption. A brief review" 120 : 520-524, 1984

5 Yoshimasu T, "Discoid lupus erythematosus(DLE)-like lesion induced by uracil-tegafur(UFT)" 11 : 54-57, 2001

6 Ha SJ, "Acral erythematous and hyperpigmentation induced by Tegafur" 36 : 363-366, 1998

7 Meropol NJ, "A phase 1 and pharmacokinetic study of oral uracil,futrafu,and leucovorin in patients with advanced cancer" 37 : 581-586, 1996